PFA was noninferior to cryoballoon ablation and was associated with a lower recurrence rate of atrial arrhythmia at 1 year among patients with symptomatic paroxysmal atrial fibrillation.

In the current study, researchers at Karolinska Institutet investigated the risk of cardiac arrhythmias in 599 patients with mitral valve prolapse who underwent heart surgery at Karolinska ...

Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery. European Heart Journal , 2025; DOI: 10.1093/eurheartj/ehaf195 Cite This Page : ...

PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial ... the residual burden of atrial arrhythmia is increasingly recognized ...

Artificial intelligence (AI) can help scientists identify patients at risk of a serious arrhythmia that is capable of triggering cardiac arrest and sudden death. As part of a new study to be published ...

Brainpower boosted by tapping out a specific rhythm, study finds The rhythm method: Not just what you tap, but how often, seems to have the biggest impact on hearing Depositphotos ...

Rhythm Pharmaceuticals, Inc. (RYTM) shares ended the last trading session 17.1% higher at $54.96. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

The last time I wrote about Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) it was in a Seeking Alpha article entitled "Rhythm: Upcoming sNDA Label Expansion IMCIVREE Isn't The Only Catalyst On Deck." ...

While pharma giants Novo Nordisk and Eli Lilly may have a solid hold on the obesity arena, Rhythm Pharmaceuticals is looking to corner a subset of the market with its Imcivree. About 5,000 to ...